World  /  Published 13.09.20

Vaccine: Astra resumes trials

AstraZeneca has resumed British clinical trials of its Covid-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday. Th...
By Reuters in London

India  /  Published 12.09.20

Indian vaccine clears monkey hurdle

A homegrown Indian vaccine candidate has successfully protected rhesus monkeys from the novel coronavirus disease, government and industry scientists have said, describing its immune response and prot...
By G.S. Mudur in New Delhi

India  /  Published 11.09.20

Serum Institute to suspend vaccine trial

The Pune-based Serum Institute of India said on Thursday that it would suspend its clinical trials of the Oxford candidate vaccine against the coronavirus disease, a day after the central drug regulat...
By G.S. Mudur in New Delhi

India  /  Published 10.09.20

Vaccine: Serum to continue

By Amit Roy, G.S. Mudur in London, New Delhi

World  /  Published 09.09.20

Drug firms in Covid vaccine vow

Nine drug companies issued a joint pledge on Tuesday that they would “stand with science” and not put forward a vaccine until it had been thoroughly vetted for safety and efficacy. The co...
By New York Times News Service in New York

India  /  Published 08.09.20

Oxford Covid-19 vaccine to roll out next year

The Oxford University vaccine for Covid-19 is “likely” to be ready early next year and in the best-case scenario later this year, UK health secretary Matt Hancock told the London radio sta...
By Amit Roy in London

India  /  Published 06.09.20

Vaccine: firms plan pledge

A group of drug companies competing with one another to be among the first to develop coronavirus vaccines are planning to pledge early next week that they will not release any vaccines that do not fo...
By New York Times News Service in New York

World  /  Published 05.09.20

Vaccine: Russia upbeat

Russia’s candidate vaccine against Covid-19 is safe and generates an immune response, Russian researchers said on Friday in their first scientific paper on the vaccine that they want mass produc...
By G.S. Mudur in New Delhi

World  /  Published 04.09.20

Covid: US hints at Oct vaccine surprise

The US federal government has told states to prepare for a coronavirus vaccine to be ready to distribute by November 1.  The timeline raised concern among public health experts about an “O...
By AP in Providence, Rhode Island

Opinion  /  Published 31.08.20

Greedy: 'Vaccine nationalism'

Nationalism is an evolving phenomenon. That perhaps explains the reason for its various mutations. Among these new forms, ‘vaccine nationalism’ has, understandably, raised concern around t...
By The Editorial Board in


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.